Sue North
About Sue North
Sue North serves as the Associate Director of Clinical Operations at Nektar Therapeutics, where she has worked since 2018. With over 25 years of project management experience and a focus on oncology clinical research, she has a proven track record in managing complex projects and leading teams in a virtual environment.
Work at Nektar Therapeutics
Sue North holds the position of Associate Director in Clinical Operations at Nektar Therapeutics. She has been with the company since 2018, contributing to the organization for six years. Her role is home-based, allowing her to manage operations effectively in a virtual environment. North leads teams that span across global geographies, ensuring that projects are executed efficiently and effectively.
Education and Expertise
Sue North has an extensive educational background. She earned a Master of Science in Clinical Investigation from the MGH Institute of Health Professions, where she studied from 2003 to 2007. Prior to that, she obtained a Bachelor of Science in Chemistry from Saint Lawrence University, completing her studies from 1972 to 1976. Additionally, she holds an MBA in Business Administration and Management from Babson College, which she pursued from 1979 to 1984. This diverse educational foundation supports her expertise in project management and clinical research.
Background
With over 25 years of experience in project management, Sue North has developed a strong background in managing complex projects. Her career includes more than 15 years specifically focused on clinical research, particularly in oncology. North has demonstrated her ability to lead teams effectively in a virtual setting, managing diverse groups across different geographical locations.
Achievements
Sue North has successfully led numerous clinical studies while maintaining adherence to projected budgets, showcasing her financial management skills. She has significant experience in the development and deployment of electronic Patient-Reported Outcomes (ePROs) systems, contributing to advancements in clinical research methodologies. Her leadership in these areas reflects her commitment to improving clinical operations and outcomes.